<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3323">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02107001</url>
  </required_header>
  <id_info>
    <org_study_id>UPP08032014</org_study_id>
    <nct_id>NCT02107001</nct_id>
  </id_info>
  <brief_title>Lung Ultrasound in Pleuritic Chest Pain</brief_title>
  <acronym>UPP</acronym>
  <official_title>Lung Ultrasound in Pleuritic Chest Pain: a Multicenter, Prospective, Diagnostic Accuracy Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chest pain is an alarming symptom and one of the most frequent causes of access to the
      Emergency Departement. Although chest X-ray remains an essential step in the diagnostic
      process, several studies showed numerous limitations of radiography which frequently is
      inconclusive. Ultrasonography is a non-radiating imaging technique. Albeit a wide use of
      ultrasound, the utilization of ultrasound in the study of the lung has only recently been
      introduced in the clinical practice. Several studies proved that lung ultrasound is useful
      in the diagnosis of lung consolidation in community acquired pneumonia. Nowadays, ultrasound
      is not routinely used in the presence of chest pain. Our hypothesis based on clinical
      experience is that, in patients with pleuritic chest pain, lung ultrasound is very sensitive
      in detecting pneumonia and other lung diseases (such as pneumothorax) thus performing better
      than radiography. The primary aim of this study is to verify, in patients affected by
      pleuritic chest pain, the accuracy of lung ultrasound compared to chest-X-ray. The secondary
      aim is to evaluate the accuracy of lung ultrasound consolidations in distinguishing lung
      consolidation in pneumonia, atelectasis, pulmonary infarction, or tumors.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Sensitivity and specificity of lung ultrasound in pneumonia, chest wall pain,  lung cancer, pulmonary embolism or other causes in patients presenting with pleuritic chest pain.</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Sensitivity and specificity, positive and negative predictive values of lung ultrasound in pneumonia, chest wall pain, lung cancer, pulmonary embolism or other causes in patients presenting with pleuritic chest pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy of ultrasound in distinguishing lung consolidation in pneumonia, atelectasis, pulmonary infarction or tumors</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Accuracy of ultrasound in differentiating consolidation in distinguishing lung consolidation in pneumonia, atelectasis, pulmonary infarction, tumors or other diseases with respect to the final diagnosis stated by a scientific committee.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Community Acquired Pneumonia</condition>
  <condition>Pleuritis</condition>
  <condition>Pulmonary Embolism</condition>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Patients with pleuritic chest pain</arm_group_label>
    <description>Study investigators will perform lung ultrasound in each patient with pleuritic chest pain at inclusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lung ultrasound</intervention_name>
    <description>Lung ultrasonography performed and interpreted by a physician (Pulmonologist or Emergency Physician) possessing specific knowledge in the procedure and a training of at least 100 thoracic ultrasonographies in accordance to a prespecified protocol.</description>
    <arm_group_label>Patients with pleuritic chest pain</arm_group_label>
    <other_name>Lung sonography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Inpatients and outpatients presenting with pleuritic chest pain referred for medical
        consultation to italian university and clinical hospitals.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient aged 18 years and older

          -  patient affected by thoracic pleuritic pain

        Exclusion Criteria:

          -  patient affected by a chronic condition causing thoracic pain

          -  patient affected by acute cardiovascular diseases (e.g. acute coronary syndrome)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Francesco Sferrazza Papa, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano, Milan, Italy.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefano Centanni, M.D, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano, Milan, Italy.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Volpicelli, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Emergency Medicine staff Physician San Luigi Gonzaga University Hospital Torino, Italy.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe Francesco Sferrazza Papa, M.D.</last_name>
    <phone>+39.281843022</phone>
    <phone_ext>3023</phone_ext>
    <email>francesco.sferrazza@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Emergency Department, Azienda Ospedaliera Universitaria Careggi, Firenze.</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>USC Pneumologia, Azienda Ospedaliera della Provincia di Lodi</name>
      <address>
        <city>Lodi</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mariano Scozzafava, M.D.</last_name>
      <email>mariano.scozzafava@ao.lodi.it</email>
    </contact>
    <investigator>
      <last_name>Mariano Scozzafava, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sara Martinenghi, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano.</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Francesco Sferrazza Papa, M.D.</last_name>
      <phone>+39281843022</phone>
      <phone_ext>f</phone_ext>
      <email>francesco.sferrazza@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Fabiano Di Marco, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michele Mondoni, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paolo Carlucci, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emergency Department, San Paolo Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Livio Colombo, M.D.</last_name>
      <email>liviocolombo@me.com</email>
    </contact>
    <investigator>
      <last_name>Livio Colombo, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>- U.O.C Broncopneumologia, IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano.</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>S.O.C. Pneumologia, Ospedale S. Luca, Rovigo.</name>
      <address>
        <city>Rovigo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>- Dipartimento di Medicina d'Urgenza, Ospedale Universitario, S. Luigi Gonzaga, Orbassano (TO).</name>
      <address>
        <city>Turin</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 3, 2014</lastchanged_date>
  <firstreceived_date>April 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>Fabiano Di Marco</investigator_full_name>
    <investigator_title>M.D., Ph.D.</investigator_title>
  </responsible_party>
  <keyword>Lung ultrasound</keyword>
  <keyword>Community acquired p neumonia (CAP)</keyword>
  <keyword>Pleuritis</keyword>
  <keyword>Pulmonary embolism</keyword>
  <keyword>Lung Cancer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chest Pain</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Pleurisy</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
